Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C12H19NO3 |
| Molecular Weight | 225.2842 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NC[C@H](O)COC1=CC=C(O)C=C1
InChI
InChIKey=ADUKCCWBEDSMEB-NSHDSACASA-N
InChI=1S/C12H19NO3/c1-9(2)13-7-11(15)8-16-12-5-3-10(14)4-6-12/h3-6,9,11,13-15H,7-8H2,1-2H3/t11-/m0/s1
| Molecular Formula | C12H19NO3 |
| Molecular Weight | 225.2842 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Towards a thermodynamic definition of efficacy in partial agonism: The thermodynamics of efficacy and ligand proton transfer in a G protein-coupled receptor of the rhodopsin class. | 2010-11-15 |
|
| Role of selective alpha and beta adrenergic receptor mechanisms in rat jejunal longitudinal muscle contractility. | 2008-06 |
|
| beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells. | 2007-09-10 |
|
| Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats. | 2006-11 |
|
| Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats. | 2005-11 |
|
| Regulation of postburn ischemia by alpha- and beta-adrenoceptor subtypes. | 2005-03 |
|
| alpha- and beta-adrenergic receptor mechanisms in spontaneous contractile activity of rat ileal longitudinal smooth muscle. | 2005-02 |
|
| Atypical cardiostimulant beta-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues. | 2003-08 |
|
| Ion-selective electrode for the determination of prenalterol. | 2003-05-01 |
|
| [Monoclonal gammopathy of undetermined significance (MGUS): establishment of premyeloma concept]. | 2002-07 |
|
| Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists. | 1999-11 |
|
| beta1 to beta3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct beta-adrenoceptor subtype mediation of proliferation and differentiation. | 1999-09 |
|
| Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate. | 1992-01 |
|
| Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. | 1989-03 |
|
| Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation. | 1984-06 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7270401
The eight patients were given prenalterol (PNL) orally, 30 to 200 mg/day, versus placebo for 6 days
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:59:33 GMT 2025
by
admin
on
Mon Mar 31 18:59:33 GMT 2025
|
| Record UNII |
M4G34404CX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QC01CA13
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
||
|
WHO-ATC |
C01CA13
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4121
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
D011294
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
M4G34404CX
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
100000081428
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
42396
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
DB13777
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
C174691
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
DTXSID8023507
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
260-791-5
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
Prenalterol
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
SUB10027MIG
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
57526-81-5
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
2258
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL1160714
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | |||
|
m9123
Created by
admin on Mon Mar 31 18:59:33 GMT 2025 , Edited by admin on Mon Mar 31 18:59:33 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
RACEMATE -> ENANTIOMER |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |